Who has invested in Gamida Cell?

Novartis are named among the investors backing Gamida Cell.

Gamida Cell Funding: $65M Raised, Growth (2022)

Gamida Cell funding overview

Gamida Cell is based in Boston, MA. Gamida Cell has raised $65M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Growth announced in September 2022. The round record for Gamida Cell runs through 2022; nothing later has been disclosed. Investors on record include Novartis.

Gamida Cell at a glance

Total raised: $65M
Latest round: Growth
Latest round date: September 2022
Headquarters: Boston, MA
Notable investors: Novartis

Frequently asked about Gamida Cell funding

How much has Gamida Cell raised?: Gamida Cell has raised $65M in total disclosed funding across the rounds on record.
Who has invested in Gamida Cell?: Novartis are named among the investors backing Gamida Cell.
What was the latest Gamida Cell funding round?: The most recent disclosed round is a Growth, announced in September 2022.
Where is Gamida Cell based?: Gamida Cell is based in Boston, MA.
When did Gamida Cell last raise?: The last disclosed Gamida Cell round closed in September 2022 at Growth.

Every Gamida Cell figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Boston at a similar stage.

Gamida Cell Funding: $65M Raised, Growth (2022)

Gamida Cell funding overview

Gamida Cell at a glance

Frequently asked about Gamida Cell funding

Companies related to Gamida Cell (36)

Browse related funding lists (6)